Conjunctivalhyperemia was graded using theCorneaand ContactLensResearch Unit (CCLRU) grading scale (0 = none; 1 = very slight; 2 = slight; 3 = moderate; 4 = severe). A larger reduction in hyperemia favoring EYSUVIS was observed at Day 15 in all four trials (Figure 2). Figure 2: M...
The article discusses the results of the Age-Related Eye Disease Study 1 (AREDS1) and AREDS 2. It mentions that AREDS 1 revealed reduction in progression of age related macular degeneration (AMD) with antioxidants and zi...
In macular degeneration, the macula is slowly destroyed, often due to free radical damage or exposure to dangerous short-wave light frequencies from the sun. As macular degeneration progresses, the center of the visual field first becomes blurry, then obscured, and finally resolves into a dark, ...